Genxone (WAR:GX1) Market Cap : zł18.18 Mil (As of Apr. 02, 2025)

View and export this data going back to 2020. Start your Free Trial

What is Genxone Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Genxone's share price for the quarter that ended in Dec. 2024 was zł6.2. Genxone's Shares Outstanding (EOP) for the quarter that ended in Dec. 2024 was 3.31 Mil. Therefore, Genxone's market cap for the quarter that ended in Dec. 2024 was zł20.49 Mil.

Genxone's quarterly market cap declined from Jun. 2024 (zł20.49 Mil) to Sep. 2024 (zł19.17 Mil) but then increased from Sep. 2024 (zł19.17 Mil) to Dec. 2024 (zł20.49 Mil).

Genxone's annual market cap declined from Dec. 2022 (zł33.67 Mil) to Dec. 2023 (zł17.74 Mil) but then increased from Dec. 2023 (zł17.74 Mil) to Dec. 2024 (zł20.49 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Genxone's Enterprise Value for Today is zł12.73 Mil.

Genxone Market Cap Historical Data

The historical data trend for Genxone's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genxone Market Cap Chart

Genxone Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Market Cap

Get a 7-Day Free Trial

69.13

69.20

33.67

17.74

20.49

Genxone Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Market Cap	Get a 7-Day Free Trial															17.74	19.98	20.49	19.17	20.49

Competitive Comparison of Genxone's Market Cap

For the Biotechnology subindustry, Genxone's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Genxone's Market Cap Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Genxone's Market Cap distribution charts can be found below:

* The bar in red indicates where Genxone's Market Cap falls into.

Save Embed

;

Save Embed

;

Genxone Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Genxone's Market Cap for the fiscal year that ended in Dec. 2024 is calculated as

Market Cap (A: Dec. 2024 )	=	Share Price (A: Dec. 2024 )	*	Shares Outstanding (EOP) (A: Dec. 2024 )
	=	zł6.2	*	3.305
	=	zł20.49

Genxone's Market Cap for the quarter that ended in Dec. 2024 is calculated as

Market Cap (Q: Dec. 2024 )	=	Share Price (Q: Dec. 2024 )	*	Shares Outstanding (EOP) (Q: Dec. 2024 )
	=	zł6.2	*	3.305
	=	zł20.49

Genxone (WAR:GX1) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.

Genxone Market Cap Related Terms

Thank you for viewing the detailed overview of Genxone's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.

Genxone Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Genxone SA (WAR:GX1) » Definitions » Market Cap

Comparable Companies

Traded in Other Exchanges

N/A

Address

ul. Kobaltowa 6, Zlotniki, Suchy Las, POL, 62-002

Website

https://www.genxone.eu

Genxone SA is a biotechnology company that applies nanopore sequencing technology (third-generation of NGS) to many areas of science and business, including genetic diagnostics and the food industry. It specializes in developing new products and solutions based on the latest technologies of nucleic acid sequencing. The company's services include NANOPORE SEQUENCING that includes Whole Genome Sequencing, Bespoke Analysis, Metagenome Sequencing, Bioinformatic Analysis, 16S and/or ITS Gene Sequencing, and RNA Sequencing; and DIAGNOSTIC TESTS that includes Gastrointestinal Infections Panel, Respiratory Infections Panel, Urogenital Infection Panel, and Nervous System Infection Panel.

Genxone Headlines

No Headlines